Try our Advanced Search for more refined results

In Re: Nexium (Esomeprazole) Antitrust Litigation

Track this case

Case overview

Case Number:

1:12-md-02409

Court:

Massachusetts

Nature of Suit:

Anti-Trust

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

William G. Young

Firms

Companies

Sectors & Industries:

  1. February 05, 2015

    Nexium Buyers Call Drug Cos. 'Serial' Antitrust Violators

    Nexium purchasers on Thursday defended their bid for an injunction against Ranbaxy Inc. and AstraZeneca PLC despite losing a recent pay-for-delay trial over the heartburn drug, arguing that the companies are "serial violators" of antitrust law.

  2. February 02, 2015

    AstraZeneca, Ranbaxy Scoff At Request For New Nexium Trial

    Ranbaxy Inc. and AstraZeneca PLC on Friday blasted the plaintiffs' request for a new trial in an antitrust action that accused the drugmakers of using a patent settlement to delay the launch of a cheaper generic version of heartburn treatment Nexium, saying a new trial is not warranted.

  3. January 27, 2015

    Ranbaxy, AstraZeneca Say Pay-For-Delay Deal Is Not Unlawful

    Ranbaxy Inc. and AstraZeneca PLC urged a Massachusetts federal judge Monday to deny the plaintiffs' bid for a permanent injunction in Nexium antitrust multidistrict litigation nearly two months after a jury ruled in favor of the defendants, with Ranbaxy saying the plaintiffs have an "epic case of denial."

  4. January 08, 2015

    Judge Urged to Kill AstraZeneca, Ranbaxy Pay-For-Delay Deal

    Some plaintiffs in the Nexium antitrust case on Wednesday urged a Massachusetts federal judge to permanently ban AstraZeneca PLC from entering into settlements to delay introduction of generic drugs into the market, telling the judge that the jury's finding that AstraZeneca's agreements are anticompetitive backs the need for an injunction.

  5. January 02, 2015

    Nexium Buyers Seek New Trial In Pay-For-Delay Case

    A group of Nexium buyers has asked a Massachusetts federal court for a new trial over antitrust claims that AstraZeneca PLC and Ranbaxy Inc. used a patent settlement to delay the launch of a cheaper generic version of the heartburn treatment.

  6. December 05, 2014

    Jury Hands AstraZeneca Win In Nexium Pay-For-Delay Case

    A Massachusetts federal jury sided with defendants AstraZeneca PLC and Ranbaxy Inc. in the first pay-for-delay class action trial since the U.S. Supreme Court agreed the patent settlements could face antitrust scrutiny, finding that AstraZeneca would never have allowed a generic Nexium to launch before its medicine patents expired.

  7. December 03, 2014

    Nexium Buyers End Trial Saying AstraZeneca Paid Off Rivals

    As the first pay-for-delay class action trial drew to a close Wednesday, Nexium buyers told the jury that AstraZeneca PLC had stalled generic versions of the heartburn treatment by giving Ranbaxy Inc. a promise worth hundreds of millions of dollars that it wouldn't launch a competing authorized generic.

  8. December 02, 2014

    No Proof Of Big Payment, AstraZeneca Says At Nexium Trial

    AstraZeneca PLC urged a Massachusetts federal judge to award it judgment on all claims made by plaintiffs in a pay-for-delay trial over the heartburn drug Nexium, saying Tuesday that no reasonable jury could find the drug manufacturer had made an unjustified payment to Ranbaxy Inc.

  9. November 24, 2014

    AstraZeneca Can't End Nexium Pay-For-Delay Trial

    A Massachusetts federal judge on Monday refused to allow AstraZeneca PLC and Ranbaxy Inc. to end a pay-for-delay trial over the heartburn drug Nexium, saying the case should go before a jury, while Teva Pharmaceutical Industries Ltd. opted to settle with the plaintiffs.

  10. November 21, 2014

    Nexium Pay-For-Delay Plaintiffs Can't Prove Conspiracy

    A Massachusetts federal judge on Friday narrowed the plaintiffs' theories in a pay-for-delay trial against AstraZeneca PLC and two generic producers over the heartburn drug Nexium, ruling there wasn't enough evidence to find that the generic companies had conspired together.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!